Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Alex A. Adjei
Based on 5 articles published since 2010
(Why 5 articles?)
||||
Expertise Level
The expertise of Alex A. Adjei ranks in the
  • Top 5.5%
  • ... of 120,378 published authors worldwide on Melanoma
  • ... from 2010 through 2020
  • ... based on contributions to 5 articles on the topic.
Graphical view (beta)
Aliases Adjei, Alex A   ·   Adjei, Alex
Work Locations
Details
Most likely:    Mayo Clinic Rochester      
2019
  • Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA. · Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida, USA. · Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. · Division of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota, USA. · Department of Immunology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA. · Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida, USA · Pubmed 31036771
2017
  • Department of Oncology, Mayo Clinic, 200 First St, SW, Rochester, MN, 55905, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Yale University, New Haven, CT, USA. · University of California at Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · New York University Langone Medical Center, New York, NY, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. · AstraZeneca Pharmaceuticals, Waltham, MA, USA. · Present address: Array BioPharma Inc., Boulder, CO, USA. · Pubmed 27650277
Probable:    Roswell Park Cancer Institute   Contact    
2018
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Translational Genomics Research Institute, Phoenix, Arizona, USA; Virginia G. Piper Cancer Center, Scottsdale, Arizona, USA. · Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA. · The University of Auckland and Auckland City Hospital, Auckland, New Zealand. · Department of International Medicine, Chaim Sheba Medical Center, Tel-HaShomer, Israel. · University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA. · Merck & Co. Inc., Kenilworth, New Jersey, USA. · Jonsson Comprehensive Cancer Center at UCLA, University of California Los Angeles, Los Angeles, California, USA. · Pubmed 29467321
2017
  • Department of Oncology, Mayo Clinic, 200 First St, SW, Rochester, MN, 55905, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Yale University, New Haven, CT, USA. · University of California at Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · New York University Langone Medical Center, New York, NY, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. · AstraZeneca Pharmaceuticals, Waltham, MA, USA. · Present address: Array BioPharma Inc., Boulder, CO, USA. · Pubmed 27650277
2016
  • David Geffen School of Medicine, UCLA, 2020 Santa Monica Blvd, Suite 600, Santa Monica, CA, 90404, USA. · Yale University, New Haven, CT, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · David Geffen School of Medicine, UCLA, 2020 Santa Monica Blvd, Suite 600, Santa Monica, CA, 90404, USA. · Karmanos Cancer Institute, Detroit, MI, USA. · Stanford University, Stanford, CA, USA. · Exelixis, Inc., South San Francisco, CA, USA. · Baxalta, Cambridge, MA, USA. · Arvinas, New Haven, CT, USA. · Nektar Therapeutics, San Francisco, CA, USA. · Genentech, Inc., South San Francisco, CA, USA. · Pubmed 27424159
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Alex A. Adjei in 2010-2020 about Melanoma:

  • Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal? 2019
  • Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors. 2018
  • CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy. 2018
  • A phase I dose-escalation study of TAK-733, an investigational oral MEK inhibitor, in patients with advanced solid tumors. 2017
  • A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors. 2016
Show List of Full Article Records
Google Searches

Learn more about Alex A. Adjei using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Mayo Clinic Rochester
Roswell Park Cancer Institute
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Mayo Clinic Rochester
2019
  • Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA. · Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida, USA. · Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. · Division of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota, USA. · Department of Immunology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA. · Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida, USA · Pubmed 31036771
2017
  • Department of Oncology, Mayo Clinic, 200 First St, SW, Rochester, MN, 55905, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Yale University, New Haven, CT, USA. · University of California at Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · New York University Langone Medical Center, New York, NY, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. · AstraZeneca Pharmaceuticals, Waltham, MA, USA. · Present address: Array BioPharma Inc., Boulder, CO, USA. · Pubmed 27650277
Roswell Park Cancer Institute
2018
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Translational Genomics Research Institute, Phoenix, Arizona, USA; Virginia G. Piper Cancer Center, Scottsdale, Arizona, USA. · Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA. · The University of Auckland and Auckland City Hospital, Auckland, New Zealand. · Department of International Medicine, Chaim Sheba Medical Center, Tel-HaShomer, Israel. · University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA. · Merck & Co. Inc., Kenilworth, New Jersey, USA. · Jonsson Comprehensive Cancer Center at UCLA, University of California Los Angeles, Los Angeles, California, USA. · Pubmed 29467321
2017
  • Department of Oncology, Mayo Clinic, 200 First St, SW, Rochester, MN, 55905, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Yale University, New Haven, CT, USA. · University of California at Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · New York University Langone Medical Center, New York, NY, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. · AstraZeneca Pharmaceuticals, Waltham, MA, USA. · Present address: Array BioPharma Inc., Boulder, CO, USA. · Pubmed 27650277
2016
  • David Geffen School of Medicine, UCLA, 2020 Santa Monica Blvd, Suite 600, Santa Monica, CA, 90404, USA. · Yale University, New Haven, CT, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · David Geffen School of Medicine, UCLA, 2020 Santa Monica Blvd, Suite 600, Santa Monica, CA, 90404, USA. · Karmanos Cancer Institute, Detroit, MI, USA. · Stanford University, Stanford, CA, USA. · Exelixis, Inc., South San Francisco, CA, USA. · Baxalta, Cambridge, MA, USA. · Arvinas, New Haven, CT, USA. · Nektar Therapeutics, San Francisco, CA, USA. · Genentech, Inc., South San Francisco, CA, USA. · Pubmed 27424159
Unspecified
2018
  • Division of Medical Oncology. · Department of Urology. · Mayo Clinic Cancer Center Early Therapeutic Program. · Mayo Clinic Center of Individualized Medicine. · Department of Biomedical Statistics and Informatics. · Department of Radiation Oncology, and. · Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA. · Pubmed 29669928
Yearly article counts 01211000000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.